環旭電子(601231.SH):第二期核心員工持股計劃的受讓價為12.665元/股
格隆匯12月16日丨環旭電子(601231.SH)披露第二期核心員工持股計劃實施進展,第二期核心員工持股計劃的受讓價格為12.665元/股。
第二期核心員工持股計劃參加人數18人,其中公司董事(不含獨立董事)、監事及高級管理人員13人,分別為陳昌益、魏鎮炎、李志成、魏振隆、陳逢達、林大毅、劉鴻祺、石孟國、史金鵬、劉丹陽、遊家雄、邱宗義、林嶽明,合計獲授152.005萬股,其餘持有人合計獲授26萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.